Global Induced Pluripotent Stem Cells (iPSc) Market Research Report 2022 (Status and Outlook)

1 Research Methodology and Statistical Scope1
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSc)1
1.2 Key Market Segments1
1.2.1 Induced Pluripotent Stem Cells (iPSc) Segment by Type1
1.2.2 Induced Pluripotent Stem Cells (iPSc) Segment by Application2
1.3 Methodology & Sources of Information3
1.3.1 Research Methodology3
1.3.2 Research Process4
1.3.3 Market Breakdown and Data Triangulation5
1.3.4 Base Year5
1.3.5 Report Assumptions & Caveats6

2 Induced Pluripotent Stem Cells (iPSc) Market Overview8
2.1 Global Market Overview8
2.1.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Estimates and Forecasts (2017-2028)8
2.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Estimates and Forecasts (2017-2028)9
2.2 Market Segment Executive Summary9
2.3 Global Market Size by Region11

3 Induced Pluripotent Stem Cells (iPSc) Market Competitive Landscape13
3.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2017-2022)13
3.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2017-2022)15
3.3 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)16
3.4 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2017-2022)17
3.5 Manufacturers Induced Pluripotent Stem Cells (iPSc) Sales Sites, Area Served, Product Type18
3.6 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends19
3.6.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate19
3.6.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue21
3.6.3 Mergers & Acquisitions, Expansion21

4 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis22
4.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials22
4.3 Midstream Market Analysis23
4.4 Downstream Customer Analysis23

5 The Development and Dynamics of Induced Pluripotent Stem Cells (iPSc) Market25
5.1 Key Development Trends25
5.2 Driving Factors25
5.3 Market Challenges25
5.4 Market Restraints26
5.5 Industry News26
5.5.1 New Product Developments26
5.5.2 Mergers & Acquisitions26
5.5.3 Expansions26
5.5.4 Collaboration/Supply Contracts26
5.6 Industry Policies26

6 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Type27
6.1 Evaluation Matrix of Segment Market Development Potential (Type)27
6.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2017-2022)28
6.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2017-2022)29
6.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2017-2022)30

7 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Application31
7.1 Evaluation Matrix of Segment Market Development Potential (Application)31
7.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2017-2022)32
7.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2017-2022)33
7.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2017-2022)34

8 Induced Pluripotent Stem Cells (iPSc) Market Segmentation by Region35
8.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region35
8.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region35
8.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region35
8.2 North America36
8.2.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country36
8.2.2 U.S.37
8.2.3 Canada37
8.2.4 Mexico37
8.3 Europe37
8.3.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country38
8.3.2 Germany38
8.3.3 France38
8.3.4 U.K.38
8.3.5 Italy39
8.3.6 Russia39
8.4 Asia Pacific39
8.4.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region39
8.4.2 China40
8.4.3 Japan40
8.4.4 South Korea40
8.4.5 India40
8.4.6 Southeast Asia40
8.5 South America40
8.5.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country41
8.5.2 Brazil41
8.5.3 Argentina41
8.5.4 Columbia41
8.6 Middle East and Africa41
8.6.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region42
8.6.2 Saudi Arabia42
8.6.3 UAE42
8.6.4 Egypt42
8.6.5 Nigeria43
8.6.6 South Africa43

9 Key Companies Profiled44
9.1 Lonza44
9.1.1 Lonza Induced Pluripotent Stem Cells (iPSc) Basic Information44
9.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview44
9.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance44
9.1.4 Lonza Business Overview45
9.1.5 Lonza Induced Pluripotent Stem Cells (iPSc) SWOT Analysis45
9.1.6 Lonza Recent Developments45
9.2 Axol Bioscience Ltd.46
9.2.1 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information46
9.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview46
9.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance46
9.2.4 Axol Bioscience Ltd. Business Overview47
9.2.5 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis47
9.2.6 Axol Bioscience Ltd. Recent Developments47
9.3 Evotec47
9.3.1 Evotec Induced Pluripotent Stem Cells (iPSc) Basic Information47
9.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview48
9.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance48
9.3.4 Evotec Business Overview48
9.3.5 Evotec Induced Pluripotent Stem Cells (iPSc) SWOT Analysis49
9.3.6 Evotec Recent Developments49
9.4 Hitachi Ltd.49
9.4.1 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Basic Information49
9.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview50
9.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance50
9.4.4 Hitachi Ltd. Business Overview50
9.4.5 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) SWOT Analysis50
9.4.6 Hitachi Ltd. Recent Developments51
9.5 Merck KGaA51
9.5.1 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Basic Information51
9.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview51
9.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance52
9.5.4 Merck KGaA Business Overview52
9.5.5 Merck KGaA Induced Pluripotent Stem Cells (iPSc) SWOT Analysis52
9.5.6 Merck KGaA Recent Developments52
9.6 REPROCELL Inc.53
9.6.1 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information53
9.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview53
9.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance53
9.6.4 REPROCELL Inc. Business Overview54
9.6.5 REPROCELL Inc. Recent Developments54
9.7 Fate Therapeutics54
9.7.1 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Basic Information54
9.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview55
9.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance55
9.7.4 Fate Therapeutics Business Overview55
9.7.5 Fate Therapeutics Recent Developments55
9.8 Thermo Fisher Scientific, Inc.56
9.8.1 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information56
9.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview56
9.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance56
9.8.4 Thermo Fisher Scientific, Inc. Business Overview57
9.8.5 Thermo Fisher Scientific, Inc. Recent Developments57
9.9 StemCellFactory III57
9.9.1 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Basic Information57
9.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview58
9.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance58
9.9.4 StemCellFactory III Business Overview58
9.9.5 StemCellFactory III Recent Developments58
9.10 Applied StemCell Inc.59
9.10.1 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Basic Information59
9.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview59
9.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance59
9.10.4 Applied StemCell Inc. Business Overview60
9.10.5 Applied StemCell Inc. Recent Developments60
9.11 Fujifilm Holding Corporation (CDI)60
9.11.1 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Basic Information60
9.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview61
9.11.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Market Performance61
9.11.4 Fujifilm Holding Corporation (CDI) Business Overview61
9.11.5 Fujifilm Holding Corporation (CDI) Recent Developments61
9.12 Ncardia62
9.12.1 Ncardia Induced Pluripotent Stem Cells (iPSc) Basic Information62
9.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview62
9.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance62
9.12.4 Ncardia Business Overview63
9.12.5 Ncardia Recent Developments63
9.13 Sumitomo Dainippon harma63
9.13.1 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Basic Information63
9.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview64
9.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance64
9.13.4 Sumitomo Dainippon harma Business Overview64
9.13.5 Sumitomo Dainippon harma Recent Developments64
9.14 Astellas Pharma Inc65
9.14.1 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Basic Information65
9.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview65
9.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance65
9.14.4 Astellas Pharma Inc Business Overview66
9.14.5 Astellas Pharma Inc Recent Developments66
9.15 Pluricell Biotech66
9.15.1 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Basic Information66
9.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview67
9.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance67
9.15.4 Pluricell Biotech Business Overview67
9.15.5 Pluricell Biotech Recent Developments67
9.16 Cell Inspire Biotechnology68
9.16.1 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Basic Information68
9.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview68
9.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance68
9.16.4 Cell Inspire Biotechnology Business Overview69
9.16.5 Cell Inspire Biotechnology Recent Developments69
10 Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region106
10.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast106
10.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region106
10.2.1 North America Market Size Forecast by Country107
10.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country108
10.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region108
10.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country109
10.2.5 Middle East and Africa Forecasted Consumption of Induced Pluripotent Stem Cells (iPSc) by Country109
11 Forecast Market by Type and by Application (2022-2028)111
11.1 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Type (2022-2028)111
11.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028)111
11.1.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2022-2028)111
11.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSc) by Type (2022-2028)112
11.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Application (2022-2028)112
11.2.1 Global Induced Pluripotent Stem Cells (iPSc) Sales (K Units) Forecast by Application112
11.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Forecast by Application (2022-2028)113
12 Conclusion and Key Findings114